Tango Therapeutics (TNGX)
US Market

Tango Therapeutics (TNGX) Stock Price & Analysis


TNGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.47 - $11.61
Previous Close$11.26
Average Volume (3M)1.92M
Market Cap
Enterprise Value$873.96M
Total Cash (Recent Filing)$311.51M
Total Debt (Recent Filing)$39.89M
Price to Earnings (P/E)-9.3
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding88,467,269
10 Day Avg. Volume1,313,891
30 Day Avg. Volume1,918,475
Standard Deviation0.30
Financial Highlights & Ratios
Price to Book (P/B)4.52
Price to Sales (P/S)103.79
Price to Cash Flow (P/CF)-9.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue30.46
Enterprise Value/Gross Profit35.16
Enterprise Value/Ebitda-8.24
Price Target Upside50.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Tango Therapeutics’s price range in the past 12 months?
Tango Therapeutics lowest stock price was $2.47 and its highest was $11.61 in the past 12 months.
    What is Tango Therapeutics’s market cap?
    Currently, no data Available
    When is Tango Therapeutics’s upcoming earnings report date?
    Tango Therapeutics’s upcoming earnings report date is Nov 08, 2023 which is in 37 days.
      How were Tango Therapeutics’s earnings last quarter?
      Tango Therapeutics released its earnings results on Aug 07, 2023. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.326 by $0.096.
        Is Tango Therapeutics overvalued?
        According to Wall Street analysts Tango Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Tango Therapeutics pay dividends?
          Tango Therapeutics does not currently pay dividends.
          What is Tango Therapeutics’s EPS estimate?
          Tango Therapeutics’s EPS estimate is -$0.34.
            How many shares outstanding does Tango Therapeutics have?
            Tango Therapeutics has 101,738,440 shares outstanding.
              What happened to Tango Therapeutics’s price movement after its last earnings report?
              Tango Therapeutics reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.326. Following the earnings report the stock price went up 1.176%.
                Which hedge fund is a major shareholder of Tango Therapeutics?
                Among the largest hedge funds holding Tango Therapeutics’s share is Baker Bros Advisors LP. It holds Tango Therapeutics’s shares valued at 2M.


                  Tango Therapeutics Stock Smart Score

                  The Tango Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Tango Therapeutics

                  BCTG Acquisition Corp is a blank check company.


                  Top 5 ETFs holding TNGX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold TNGX. The ETFs are listed according to market value of TNGX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Fate Therapeutics
                  Crispr Therapeutics AG
                  Editas Medicine
                  TransMedics Group

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis